Sassi-Sayadi, Mouna
Verweij, Pierre
Cornelisse, Peter
Article History
Received: 3 April 2025
Accepted: 11 September 2025
First Online: 10 October 2025
Declarations
:
: Source of funding: This study was funded by Idorsia Pharmaceuticals Ltd.; Disclosures: MSS, PV and PC were employees of Idorsia Pharmaceuticals Ltd. when the manuscript was developed. Currently, MSS is employed at Viatris, PV is an employee of Radboud University Medical Centre Nijmegen and PC is an employee of Voisin Consulting Life Sciences.